跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
GIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
GIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Paion Pharma Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 31, 2023
Approval ID
bb6d29cb957e26bc
Company
Paion Pharma Gmbh
Type
Standard
Approval Details
Approval Id
bb6d29cb957e26bc
Drug Cima Aemps Name
GIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1191384003
Holder Company Name
Paion Pharma Gmbh
Marketing Company Name
Viatris Pharmaceuticals S.L.U.
Holder Company Detail Path
/organization/paion-pharma-gmbh
Authorization Date
2023-07-31
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
2,5 MG/ML
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Paion Pharma Gmbh
Company Detail Path
/organization/paion-pharma-gmbh
Company Information
Pharmaceutical Company Name
Paion Pharma GmbH
Country Name
Germany
City Name
aachen,nordrhein-westfalen,country_de
Address
Heussstr. 25
Active Ingredients
ANGIOTENSINA II ACETATO
2,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 31, 2023
Approval ID
bb6d29cb957e26bc
Type
Standard
Back to CIMA-AEMPS Approvals